"The Morgans Life Sciences Index...(like the NASDAQ Biotech Index) is retracing after a very good run through the second half of 2013. As the Index becomes increasingly stock-specific and patchy, seek out companies with near-term positive news flow. Two such companies are Qrxpharma Ltd - QRX (Advisory Committee meeting this month to discuss and recommend MOXDUO) and Neuren Pharmaceutical - NEU (completing recruitment for Retts Phase 2 trial in 2QCY14)."
QRX Price at posting:
83.0¢ Sentiment: Hold Disclosure: Held
